자가 줄기세포 및 비줄기세포 기반 치료 시장 규모는 앞으로 수년간 급성장할 것으로 예상됩니다. 2029년에는 CAGR 16.1%를 나타내 210억 7,000만 달러로 성장할 것으로 전망됩니다. 예측 기간의 성장은 대상 질환의 유병률 상승, 노년 인구 증가, 신경퇴행성 질환의 유병률 상승, 암 증례 수 증가, 피부 이식 수요 증가, 재생 의료에 대한 의식의 고조, 주요 기업간의 제휴나 파트너십, 승인된 치료법에 대한 상환의 개선 등에 기인하는 것으로 예상됩니다. 예측기간의 주요 동향으로는 인공지능과 머신러닝의 통합, 기제의 동종 줄기세포 제품의 개발, 상환 정책의 확대, 신규 생체 재료의 채용, 세포 제조 기술의 진보, 자가 줄기세포 요법의 채용, 유전자 편집 기술의 통합 등을 들 수 있습니다.
맞춤형 치료에 대한 수요 증가가 당면간 자가 줄기세포 및 비줄기세포 기반 치료 시장의 성장을 견인하게 될 것으로 보입니다. 개인화된 치료란 개인의 유전학, 라이프스타일, 선호도에 따라 이익을 극대화하고 부작용을 최소화하도록 조정된 치료를 의미합니다. 맞춤형 치료가 급증하고 있는 배경에는 유전학이나 기술의 진보에 의해 부작용을 억제하면서 보다 정밀하고 효과적인 치료가 가능하게 된 것, 맞춤형 치료에 대한 환자의 기호성이 높아지고 있는 것, 헬스케어에 있어서의 비용 절감의 가능성 등, 몇가지 요인이 생각됩니다. 맞춤형 치료는 각 개인의 유전적 특징이나 건강 상태에 맞추어, 자가 줄기세포나 비줄기세포를 이용한 치료를 최적화하는 것으로, 치료 성적의 향상이나 합병증의 감소로 이어집니다. 예를 들어, 2022년 맞춤형 의료연합이 발표한 데이터에 따르면, 12개 개인화 신약의 승인은 새로 승인된 전체 치료법의 약 34%를 차지하며 이전보다 상당히 증가한 것으로 나타났습니다. 따라서 개인화 치료에 대한 수요 증가는 자가 줄기세포 및 비줄기세포 기반 치료 시장의 원동력이 되고 있습니다.
자가 줄기세포 및 비줄기세포 기반 치료 시장의 유력 기업은 개별화 암 치료 전략을 강화하기 위해, 종양 유래 자가 T 세포 면역 요법의 개발에 주력하고 있습니다. 예를 들면, 2024년 2월, 미국의 바이오 테크놀로지 기업인 아이 오반스 바이오세라퓨틱스사는 성인 흑색종 환자의 치료에 적응한 최초의 세포요법인 암태그비(리필류셀)에 대해 식품의약국에서 조기 승인을 취득했습니다. 기존의 자가 T 세포 면역요법인 리필류셀은 종양 침윤 림프구(TIL)로 알려진 환자의 자연발생 면역세포로 구성되어 암을 인식하고 암과 싸우는 면역계의 능력을 보다 효과적으로 높입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염, 그리고 경기 회복이 시장에 미치는 영향을 포함한 거시 경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 자가 줄기세포 및 비줄기세포 기반 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업의 분석
- 세계의 자가 줄기세포 및 비줄기세포 기반 치료 시장 : 성장률 분석
- 세계의 자가 줄기세포 및 비줄기세포 기반 치료 시장 실적 : 규모와 성장(2019-2024년)
- 세계의 자가 줄기세포 및 비줄기세포 기반 치료 시장 예측 : 규모와 성장(2024-2029년, 2034년)
- 세계의 자가 줄기세포 및 비줄기세포 기반 치료 전체 시장(TAM)
제6장 시장 세분화
- 세계의 자가 줄기세포 및 비줄기세포 기반 치료 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 자가 줄기세포
- 자가 비줄기세포
- 기타 유형
- 세계의 자가 줄기세포 및 비줄기세포 기반 치료 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 암
- 신경 퇴행성 질환
- 심혈관 질환
- 정형외과 질환
- 기타 용도
- 세계의 자가 줄기세포 및 비줄기세포 기반 치료 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 병원
- 외래수술센터(ASC)
- 연구 시설
- 기타 최종 사용자
- 세계의 자가 줄기세포 및 비줄기세포 기반 치료 시장 : 자가 줄기세포 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 조혈 줄기세포
- 중간엽 줄기세포
- 신경 줄기세포
- 혈관 내피 줄기세포
- 세계의 자가 줄기세포 및 비줄기세포 기반 치료 시장 : 자가 비줄기세포 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 혈소판 풍부 혈장(PRP)
- 지방 유래 세포
- 말초혈액 세포
- 세계의 자가 줄기세포 및 비줄기세포 기반 치료 시장 : 기타 유형별, 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 엑소좀 기반 치료법
- 조직 공학 구조물
제7장 지역별/국가별 분석
- 세계의 자가 줄기세포 및 비줄기세포 기반 치료 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 자가 줄기세포 및 비줄기세포 기반 치료 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 자가 줄기세포 및 비줄기세포 기반 치료 시장 : 경쟁 구도
- 자가 줄기세포 및 비줄기세포 기반 치료 시장 : 기업 프로파일
- Bayer AG 개요, 제품 및 서비스, 전략 및 재무 분석
- Novartis AG 개요, 제품 및 서비스, 전략 및 재무 분석
- Takeda Pharmaceutical Company Limited 개요, 제품 및 서비스, 전략 및 재무 분석
- Gilead Sciences Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Merck & Co. Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Stemcell Technologies Inc.
- Dendreon Corporation
- Vericel Corporation
- Sangamo Therapeutics Inc.
- NEOSTEM
- Orgenesis Inc.
- Adaptimmune Therapeutics
- Stempeutics Research Pvt Ltd.
- MEDIPOST
- Castle Creek Biosciences Inc.
- BrainStorm Cell Limited
- Athersys Inc.
- Cytori Therapeutics Inc.
- Opexa Therapeutics
- Gamida Cell
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 자가 줄기세포 및 비줄기세포 기반 치료 시장(2029년) : 새로운 기회를 제공하는 국가
- 자가 줄기세포 및 비줄기세포 기반 치료 시장(2029년) : 새로운 기회를 제공하는 부문
- 자가 줄기세포 및 비줄기세포 기반 치료 시장(2029년) : 성장 전략
제36장 부록
KTH
Autologous stem cell and non-stem cell-based therapies encompass treatments that utilize a patient's own cells to repair, replace, or regenerate damaged tissues and organs. In autologous stem cell therapies, stem cells are extracted from the patient, expanded or modified, and reintroduced to facilitate healing and regeneration. Non-stem cell-based therapies, on the other hand, utilize different types of cells, such as immune cells or tissue-specific cells, to achieve similar therapeutic objectives. These personalized approaches aim to mitigate the risk of immune rejection and enhance treatment efficacy for conditions such as cancer, autoimmune diseases, and degenerative disorders.
The primary types of autologous stem cell and non-stem cell-based therapies include autologous stem cells, autologous non-stem cells, and others. Autologous stem cells are derived from the patient's own body and utilized in medical therapies to facilitate the healing of damaged tissue or organs. They find application across various fields including cancer treatment, neurodegenerative disorders, cardiovascular disease, orthopedic conditions, and others, and are utilized by hospitals, ambulatory surgical centers, research facilities, and other healthcare institutions.
The autologous stem cell and non-stem cell based therapies market research report is one of a series of new reports from The Business Research Company that provides autologous stem cell and non-stem cell based therapies market statistics, including the autologous stem cell and non-stem cell based therapies industry global market size, regional shares, competitors with autologous stem cell and non-stem cell based therapies market share, detailed autologous stem cell and non-stem cell based therapies market segments, market trends, and opportunities, and any further data you may need to thrive in the autologous stem cell and non-stem cell based therapies industry. These autologous stem cell and non-stem cell based therapies market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The autologous stem cell and non-stem cell based therapies market size has grown rapidly in recent years. It will grow from $9.96 billion in 2024 to $11.59 billion in 2025 at a compound annual growth rate (CAGR) of 16.5%. The growth in the historic period can be attributed to increased prevalence of cancer and diabetes, increased numbers of geriatric individuals, growing healthcare awareness, rise in research and development activities, increased numbers of clinical trials, Increased regulatory approval.
The autologous stem cell and non-stem cell based therapies market size is expected to see rapid growth in the next few years. It will grow to $21.07 billion in 2029 at a compound annual growth rate (CAGR) of 16.1%. The growth in the forecast period can be attributed to rising prevalence of targeted diseases, an increasing geriatric population, rising prevalence of neurodegenerative diseases, growing number of cancer cases, increasing demand for skin transplantation, increasing awareness about regenerative medicine, collaborations and partnerships among key players, improving reimbursement for approved therapies. Major trends in the forecast period include the integration of artificial intelligence and machine learning, development of off-the-shelf allogeneic stem cell products, expansion of reimbursement policies, adoption of novel biomaterials, advancements in cell manufacturing technologies, adoption of autologous stem cell therapies, integration of gene editing technologies.
The increasing demand for personalized therapies is set to drive the growth of the autologous stem cell and non-stem cell-based therapies market in the foreseeable future. Personalized therapies refer to medical treatments tailored to maximize benefits and minimize adverse effects based on individual genetics, lifestyle, and preferences. This surge in personalized therapies can be attributed to several factors, including advancements in genetics and technology enabling more precise and effective treatments with reduced side effects, growing patient preference for customized care, and the potential for cost savings in healthcare. Personalized therapies optimize the utilization of autologous stem cell and non-stem cell-based treatments by tailoring them to the unique genetic and health characteristics of each individual, resulting in improved outcomes and fewer complications. For example, data from the Personalized Medicine Coalition in 2022 indicated that the approval of 12 new personalized medicines accounted for around 34% of all newly approved therapies, signaling a significant increase from previous years. Hence, the increasing demand for personalized therapies serves as a driving force for the autologous stem cell and non-stem cell-based therapies market.
Prominent companies in the autologous stem cell and non-stem cell-based therapies market are focusing on the development of tumor-derived autologous T cell immunotherapy to enhance personalized cancer treatment strategies. Tumor-derived autologous T cell immunotherapy involves extracting T cells from a patient's tumor, expanding and activating them in the laboratory, and reintroducing them into the patient to boost the immune system's ability to target and eradicate cancer cells specifically. For instance, in February 2024, Iovance Biotherapeutics, a US-based biotechnology company, obtained accelerated approval from the Food and Drug Administration for Amtagvi (lifileucel), the first cellular therapy indicated for treating adult patients with melanoma. Lifileucel, a tumor-derived autologous T-cell immunotherapy, consists of a patient's naturally occurring immune cells known as tumor-infiltrating lymphocytes (TILs), enhancing the immune system's ability to recognize and combat cancer more effectively.
In April 2022, Metcela Inc., a Japan-based biotechnology company, acquired Japan Regenerative Medicine Co. Ltd. (JRM) for an undisclosed sum. Through this acquisition, Metcela Inc. aims to expand its portfolio with an autologous cell product for pediatric congenital heart disease and leverage synergies in manufacturing and sales systems for a wide range of cardiac therapies. Japan Regenerative Medicine Co. Ltd. (JRM) specializes in developing regenerative medicine therapies for pediatric congenital heart diseases and offers services related to stem cell therapy.
Major companies operating in the autologous stem cell and non-stem cell based therapies market are Bayer AG, Novartis AG, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Merck & Co. Inc., Stemcell Technologies Inc., Dendreon Corporation, Vericel Corporation, Sangamo Therapeutics Inc., NEOSTEM, Orgenesis Inc., Adaptimmune Therapeutics, Stempeutics Research Pvt Ltd., MEDIPOST, Castle Creek Biosciences Inc., BrainStorm Cell Limited, Athersys Inc., Cytori Therapeutics Inc., Opexa Therapeutics, Gamida Cell, Regen BioPharma Inc., RepliCel Life Sciences, InGeneron Inc., BioCardia Inc., ReNeuron Group
North America was the largest region in the autologous stem cell and non-stem cell based therapies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the autologous stem cell and non-stem cell based therapies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the autologous stem cell and non-stem cell based therapies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The autologous stem cell and non-stem cell-based therapies market consists of revenues earned by entities by providing services such as patient evaluation, cell collection and processing, genetic modification, quality control, cell storage, infusion, post-treatment monitoring, regulatory compliance, and patient support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The autologous stem cell and non-stem cell-based therapies market also includes sales of platelet-rich plasma (PRP) therapy, autologous fibroblast injection, autologous dendritic cell therapy, and tumor-derived autologous T cell immunotherapy. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Autologous Stem Cell And Non-Stem Cell Based Therapies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on autologous stem cell and non-stem cell based therapies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for autologous stem cell and non-stem cell based therapies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The autologous stem cell and non-stem cell based therapies market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Autologous Stem Cells; Autologous Non-Stem Cells; Other Types
- 2) By Application: Cancer; Neurodegenerative Disorders; Cardiovascular Disease; Orthopedic Diseases; Other Applications
- 3) By End-User: Hospitals; Ambulatory Surgical Centers; Research Facilities; Other End Users
- Subsegments:
- 1) By Autologous Stem Cells: Hematopoietic Stem Cells; Mesenchymal Stem Cells; Neural Stem Cells; Endothelial Stem Cells
- 2) By Autologous Non-Stem Cells: Platelet-Rich Plasma (Prp); Adipose-Derived Cells; Peripheral Blood Cells
- 3) By Other Types: Exosome-Based Therapies; Tissue-Engineered Constructs
- Companies Mentioned: Bayer AG; Novartis AG; Takeda Pharmaceutical Company Limited; Gilead Sciences Inc.; Merck & Co. Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Autologous Stem Cell And Non-Stem Cell Based Therapies Market Characteristics
3. Autologous Stem Cell And Non-Stem Cell Based Therapies Market Trends And Strategies
4. Autologous Stem Cell And Non-Stem Cell Based Therapies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Autologous Stem Cell And Non-Stem Cell Based Therapies Growth Analysis And Strategic Analysis Framework
- 5.1. Global Autologous Stem Cell And Non-Stem Cell Based Therapies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Autologous Stem Cell And Non-Stem Cell Based Therapies Market Growth Rate Analysis
- 5.4. Global Autologous Stem Cell And Non-Stem Cell Based Therapies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Autologous Stem Cell And Non-Stem Cell Based Therapies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Autologous Stem Cell And Non-Stem Cell Based Therapies Total Addressable Market (TAM)
6. Autologous Stem Cell And Non-Stem Cell Based Therapies Market Segmentation
- 6.1. Global Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Autologous Stem Cells
- Autologous Non-Stem Cells
- Other Types
- 6.2. Global Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cancer
- Neurodegenerative Disorders
- Cardiovascular Disease
- Orthopedic Diseases
- Other Applications
- 6.3. Global Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Ambulatory Surgical Centers
- Research Facilities
- Other End Users
- 6.4. Global Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Sub-Segmentation Of Autologous Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hematopoietic Stem Cells
- Mesenchymal Stem Cells
- Neural Stem Cells
- Endothelial Stem Cells
- 6.5. Global Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Sub-Segmentation Of Autologous Non-Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Platelet-Rich Plasma (PRP)
- Adipose-Derived Cells
- Peripheral Blood Cells
- 6.6. Global Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Exosome-Based Therapies
- Tissue-Engineered Constructs
7. Autologous Stem Cell And Non-Stem Cell Based Therapies Market Regional And Country Analysis
- 7.1. Global Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Autologous Stem Cell And Non-Stem Cell Based Therapies Market
- 8.1. Asia-Pacific Autologous Stem Cell And Non-Stem Cell Based Therapies Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Autologous Stem Cell And Non-Stem Cell Based Therapies Market
- 9.1. China Autologous Stem Cell And Non-Stem Cell Based Therapies Market Overview
- 9.2. China Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Autologous Stem Cell And Non-Stem Cell Based Therapies Market
- 10.1. India Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Autologous Stem Cell And Non-Stem Cell Based Therapies Market
- 11.1. Japan Autologous Stem Cell And Non-Stem Cell Based Therapies Market Overview
- 11.2. Japan Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Autologous Stem Cell And Non-Stem Cell Based Therapies Market
- 12.1. Australia Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Autologous Stem Cell And Non-Stem Cell Based Therapies Market
- 13.1. Indonesia Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Autologous Stem Cell And Non-Stem Cell Based Therapies Market
- 14.1. South Korea Autologous Stem Cell And Non-Stem Cell Based Therapies Market Overview
- 14.2. South Korea Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Autologous Stem Cell And Non-Stem Cell Based Therapies Market
- 15.1. Western Europe Autologous Stem Cell And Non-Stem Cell Based Therapies Market Overview
- 15.2. Western Europe Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Autologous Stem Cell And Non-Stem Cell Based Therapies Market
- 16.1. UK Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Autologous Stem Cell And Non-Stem Cell Based Therapies Market
- 17.1. Germany Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Autologous Stem Cell And Non-Stem Cell Based Therapies Market
- 18.1. France Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Autologous Stem Cell And Non-Stem Cell Based Therapies Market
- 19.1. Italy Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Autologous Stem Cell And Non-Stem Cell Based Therapies Market
- 20.1. Spain Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Autologous Stem Cell And Non-Stem Cell Based Therapies Market
- 21.1. Eastern Europe Autologous Stem Cell And Non-Stem Cell Based Therapies Market Overview
- 21.2. Eastern Europe Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Autologous Stem Cell And Non-Stem Cell Based Therapies Market
- 22.1. Russia Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Autologous Stem Cell And Non-Stem Cell Based Therapies Market
- 23.1. North America Autologous Stem Cell And Non-Stem Cell Based Therapies Market Overview
- 23.2. North America Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Autologous Stem Cell And Non-Stem Cell Based Therapies Market
- 24.1. USA Autologous Stem Cell And Non-Stem Cell Based Therapies Market Overview
- 24.2. USA Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Autologous Stem Cell And Non-Stem Cell Based Therapies Market
- 25.1. Canada Autologous Stem Cell And Non-Stem Cell Based Therapies Market Overview
- 25.2. Canada Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Autologous Stem Cell And Non-Stem Cell Based Therapies Market
- 26.1. South America Autologous Stem Cell And Non-Stem Cell Based Therapies Market Overview
- 26.2. South America Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Autologous Stem Cell And Non-Stem Cell Based Therapies Market
- 27.1. Brazil Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Autologous Stem Cell And Non-Stem Cell Based Therapies Market
- 28.1. Middle East Autologous Stem Cell And Non-Stem Cell Based Therapies Market Overview
- 28.2. Middle East Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Autologous Stem Cell And Non-Stem Cell Based Therapies Market
- 29.1. Africa Autologous Stem Cell And Non-Stem Cell Based Therapies Market Overview
- 29.2. Africa Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Autologous Stem Cell And Non-Stem Cell Based Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Autologous Stem Cell And Non-Stem Cell Based Therapies Market Competitive Landscape And Company Profiles
- 30.1. Autologous Stem Cell And Non-Stem Cell Based Therapies Market Competitive Landscape
- 30.2. Autologous Stem Cell And Non-Stem Cell Based Therapies Market Company Profiles
- 30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Autologous Stem Cell And Non-Stem Cell Based Therapies Market Other Major And Innovative Companies
- 31.1. Stemcell Technologies Inc.
- 31.2. Dendreon Corporation
- 31.3. Vericel Corporation
- 31.4. Sangamo Therapeutics Inc.
- 31.5. NEOSTEM
- 31.6. Orgenesis Inc.
- 31.7. Adaptimmune Therapeutics
- 31.8. Stempeutics Research Pvt Ltd.
- 31.9. MEDIPOST
- 31.10. Castle Creek Biosciences Inc.
- 31.11. BrainStorm Cell Limited
- 31.12. Athersys Inc.
- 31.13. Cytori Therapeutics Inc.
- 31.14. Opexa Therapeutics
- 31.15. Gamida Cell
32. Global Autologous Stem Cell And Non-Stem Cell Based Therapies Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Autologous Stem Cell And Non-Stem Cell Based Therapies Market
34. Recent Developments In The Autologous Stem Cell And Non-Stem Cell Based Therapies Market
35. Autologous Stem Cell And Non-Stem Cell Based Therapies Market High Potential Countries, Segments and Strategies
- 35.1 Autologous Stem Cell And Non-Stem Cell Based Therapies Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Autologous Stem Cell And Non-Stem Cell Based Therapies Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Autologous Stem Cell And Non-Stem Cell Based Therapies Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
